reviewInternational Journal of Molecular SciencesFeb 17, 2017GOLD OA

A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments

Assistance Publique – Hôpitaux de Paris · Centre Hospitalier Universitaire de Bordeaux · +12 more institutions

PubMed
Indexed incrossrefdoajpubmed

Abstract

Gaucher disease (GD, ORPHA355) is a rare, autosomal recessive genetic disorder. It is caused by a deficiency of the lysosomal enzyme, glucocerebrosidase, which leads to an accumulation of its substrate, glucosylceramide, in macrophages. In the general population, its incidence is approximately 1/40,000 to 1/60,000 births, rising to 1/800 in Ashkenazi Jews. The main cause of the cytopenia, splenomegaly, hepatomegaly, and bone lesions associated with the disease is considered to be the infiltration of the bone marrow, spleen, and liver by Gaucher cells. Type-1 Gaucher disease, which affects the majority of patients (90% in Europe and USA, but less in other regions), is characterized by effects on the viscera,…

Citation impact

858
total citations
FWCI
33.37
Percentile
100%
References
211
Citations per year

Authors

13

Topics & keywords

Keywords
  • Enzyme replacement therapy
  • Glucocerebrosidase
  • Medicine
  • Substrate reduction therapy
  • Disease
  • Cytopenia
  • Gaucher's disease
  • Lysosomal storage disease
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.